Scientists compare immune drugs in a dish for kidney disease relapse
NCT ID NCT05428605
First seen Dec 08, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study looked at blood samples from 20 adults with relapsed membranous nephropathy, a kidney condition. Researchers tested different immune-modulating drugs in the lab to see how they affect the balance of certain immune cells (Th17 and Treg). The goal was to gather information to help choose the best treatment for future patients. This was a lab-based study, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRAMEMBRANOUS GLOMERULOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Nice
Nice, 06200, France
Conditions
Explore the condition pages connected to this study.